glycogen synthase 1 Activators

The chemicals that can influence the activity of Glycogen Synthase 1, a key enzyme in glycogenesis, are diverse and act through different mechanisms. For instance, insulin and IGF-1 can activate the PI3K/Akt pathway, which inhibits GSK3, a kinase that phosphorylates and inactivates GYS1. Hence, through the inhibition of GSK3, insulin and IGF-1 can lead to the activation of GYS1.

Similarly, metformin and AICAR, as activators of AMPK, can indirectly activate GYS1 by inhibiting GSK3. The complex role of okadaic acid, which can both inhibit protein phosphatases leading to GYS1 inactivation, and inhibit GSK3 potentially leading to GYS1 activation, underscores the interconnectedness of cellular signaling pathways. Finally, a group of chemicals including Lithium Chloride, SB216763, BIO, Indirubin-3'-monoxime, CHIR99021, Tideglusib, and Valproic Acid, all act as GSK3 inhibitors, and hence can lead to GYS1 activation. These chemicals highlight the importance of GSK3 in the regulation of GYS1 activity and the potential for chemical modulation of this pathway.